Global Drug-Coated Balloons Market to 2024: Growing Demand for DCBs to Lower Restenosis and Revascularization Rates - Major Players are Medtronic, BD, B. Braun Melsungen & Koninklijke Philips

DUBLIN, Feb. 18, 2019 /PRNewswire/ -- The "Drug-Coated Balloons Market - Global Outlook and Forecast 2019-2024" report has been added to ResearchAndMarkets.com's offering.

https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

The global drug-coated balloons market is expected to reach revenues of more than $1 billion by 2024, growing at a CAGR of around 17% during 2018-2024.

The global drug-coated balloons market is driven by the spreading awareness, education, and support for several CVDs. The DCBs market is one of the fastest growing segments in cardiovascular devices segment in the healthcare industry. The market research report provides in-depth market analysis and segmental analysis of the global drug-coated balloons market by indication, end-users, and geography.

The report considers the present scenario of the global drug-coated balloons market and its market dynamics for the period 2019-2024. It covers the market by geography (North America, Europe, APAC, and ROW); by end-users (hospitals, cardiac catheterization labs, and ambulatory surgical centers); by indication types (DCBs for peripheral artery diseases, DCBs for coronary artery diseases, and DCBs for other indications).

The study elaborates the present market scenario and discusses the futuristic demand for DCBs in the market. It also covers a detailed overview of several market growth enablers, restraints, and trends. The study includes both the demand and supply sides of the market. It also profiles and analyzes the leading companies and several other prominent companies operating in the market.

Drug-Coated Balloons Market - Dynamics

There has been an increasing usage of Drug-coated balloons over the standard PTA Balloons for treating peripheral and coronary arterial diseases. The rapid growth and need for significant improvement in MI procedures and MI surgical techniques have led to this technical improvement in the balloon catheter segment.

This significant development and launch of several drug-coated balloons have enhanced the safety, effectiveness and clinical outcomes of angioplasty procedures.A lot of vendors have a rich pipeline of devices for arterial, AVF, and AVG indications.

Significant players in the market have their own in-house R&D activities to develop and commercialize DCB's. They have promising investigational DCBs under development and most of the small players are also actively involved in the development of novel and advanced drug-coated balloon devices.

The vendors are conducting clinical trials to ensure the safety and for seeking regulatory approval from the USFDA in the coming years previously drug-coated balloons were only used for treating SFA in patients with PAD. Due to improvements in technological innovations, and increased clinical trials the application of this is expanded and used to treat other endovascular diseases. These days PAD patients with BTK artery lesions, small vessel disease, complex CAD, AVG, and AVF are also treated with advanced drug-coated balloon's. In recent years, the regulatory bodies gave expanded indication approvals for the existing commercial drug-coated balloons.

Drug-Coated Balloons Market - Segmentation

This market research report includes a detailed segmentation of the market by indication, end-users, and geography.The global drug-coated balloons market by indication is classified into DCB for peripheral artery disease, DCB for coronary artery disease, and DCB for other indications. DCB for peripheral artery disease segment dominated the majority of total market share in 2018, growing at a CAGR of over more than 16% during the forecast period.

The increasing advancements in endovascular therapy are propelling the growth of this segment in the global market. This procedure has offered a significant breakthrough and completely changed the treatment landscape of PAD, especially femoropopliteal artery disease.The growing demand for treatment options of complex coronary artery lesions, such as small-vessel disease and long diffuse CAD is fueling the growth of this segment in the global market.

The development of drug-coated balloons technology is a viable alternative treatment option for the inhibition of coronary restenosis and subsequent revascularization in patients with CAD, thereby, fueling the demand in the global DCB market. Many vascular surgeons believe that these procedures are superior and cost-effective than treating CAD with DES in the long-term in the market.

The end-user segment in the global drug-coated balloons market is categorized into hospitals, cardiac catheterization labs, and ASCs. ASCs is the fastest growing end-user segment in the global market, at a CAGR of over 19% during the forecast period. The growing shift from open cardiovascular surgical techniques toward MI and percutaneous-based procedures especially across developed countries is contributing to the growth of the ASC segment in the global market.

The technological advancements in interventional procedures, increasing demand for less invasive surgeries, and high growth in the development of out-patient services are some of the factors attributing to the rising demand for ASCs in the global market.

The growing demand for highly advanced and innovative catheter-based cardiovascular and endovascular procedures will boost the adoption of drug-coated balloons across hospitals. Hospitals in developed countries such as the US, Germany, France, and Japan are adopting these procedures. These angioplasty procedures for treating a broad range of high-risk and complicated vascular diseases are gaining immense popularity among renowned hospitals, resulting in higher revenues in the global DCB market.

Drug-Coated Balloons Market - Geography

The global drug-coated balloons market by geography is segmented into North America, Europe, APAC, and ROW. North America occupied more than half of the total market share in 2018, growing at a CAGR of more than 18% during the forecast period.

The growing prevalence of various cardiovascular risk factors, such as high BP, smoking, lack of physical activity, obesity, and diabetes are the main factors boosting the adoption of these procedures in the North American market. The availability of advanced healthcare infrastructure, constant technological innovations, and growing acceptance for advanced MI endovascular devices will create lucrative opportunities for leading vendors operating in the North American market.

The growing demand for MI endovascular procedures, changes in lifestyle patterns of people, rising geriatric population, and increasing prevalence of vascular diseases are some of the factors attributing to the growth of the European region in the global market. The development of sophisticated and established healthcare infrastructure and advanced services across Western Europe will contribute to the development of the European region in the global DCB market.

Key Vendor Analysis

The global drug-coated balloons market is highly dynamic due to the presence of international, regional, and local players. The top companies are focusing on wide geographical reach, diversified product portfolio, and a strong focus on innovation and research activities to attract a maximum of consumers in the global market.

The emerging companies to expand their presence, enhance product portfolio, and improve expertise to sustain the competition in the market. The increase in M&A activities will drive consolidation in the global drug-coated balloons market.

The major vendors in the global market are:

    --  Medtronic
    --  BD
    --  B. Braun Melsungen
    --  Koninklijke Philips

Key Topics Covered:

1 Research Methodology

2 Research Objectives

3 Research Process

4 Report Coverage
4.1 Market Definition
4.2 Base Year
4.3 Scope of Study
4.3.1 Market Segmentation by Indication Type
4.3.2 Market Segmentation by End-user Type
4.3.3 Market Segmentation by Geography

5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Inclusions
5.3 Exclusions
5.4 Currency Conversion
5.5 Market Derivation

6 Market at a Glance
7 Introduction
7.1 DCBs: An Overview
7.2 Market Snapshot

8 Market Dynamics
8.1 Market Growth Enablers
8.1.1 Availability of Abundant Clinical Data and Increased Focus on Clinical Trials
8.1.2 New Product Approvals
8.1.3 Increase in Prevalence of Cardiovascular Diseases
8.1.4 Growing Demand for DCBs to Lower Restenosis and Revascularization Rates
8.2 Market Growth Restraints
8.2.1 Threats from Substitutes
8.2.2 Regulatory Challenges for Vendors
8.2.3 Hurdles in Reimbursement Coverage
8.3 Market Opportunities & Trends
8.3.1 Availability of Latest Generation DCBs
8.3.2 Robust DCB Devices in Pipeline
8.3.3 Expanded Indication Approvals of Existing DCBs
8.3.4 Emergence of Sirolimus-coated Balloon Catheters

9 Global Drug-coated Balloons Market
9.1 Market Overview
9.2 Market Size & Forecast
9.3 Porter's Five Forces Analysis
9.3.1 Threat of New Entrants
9.3.2 Bargaining Power of Suppliers
9.3.3 Bargaining Power of Buyers
9.3.4 Threat of Substitutes
9.3.5 Competitive Rivalry

10 By Indication
10.1 Market Overview
10.2 DCBs for PAD
10.3 DCBs for CAD
10.4 DCBs for Other Indications

11 By End-users
11.1 Market Overview
11.2 Hospitals
11.3 Cardiac Catheterization Labs
11.4 ASCs

12 By Geography
12.1 Market Overview

13 North America

14 Europe

15 APAC

16 Rest of the World

17 Competitive Landscape
17.1 Competitive Scenario
17.2 Market Vendor Share/Ranking Analysis

18 Key Company Profiles
18.1 Medtronic
18.2 BD
18.3 Koninklijke Philips
18.4 B. Braun Melsungen

19 Key Companies to Watch
19.1 BIOTRONIK
19.2 Boston Scientific
19.3 Opto Circuits (India)

20 Other Prominent Vendors
20.1 Acotec Scientific
20.2 AR Baltic Medical
20.3 Acrostak
20.4 Biosensors International Group
20.5 Cardionovum
20.6 Concept Medical
20.7 ENDOCOR
20.8 Hexacath
20.9 iVascular SLU
20.10 M.A. Med Alliance
20.11 Minvasys
20.12 Orchestra BioMed
20.13 QT Vascular
20.14 RD Global-Invamed
20.15 Surmodics
20.16 Terumo
20.17 Wellinq

For more information about this report visit https://www.researchandmarkets.com/research/tg3js2/global?w=5

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/global-drug-coated-balloons-market-to-2024-growing-demand-for-dcbs-to-lower-restenosis-and-revascularization-rates---major-players-are-medtronic-bd-b-braun-melsungen--koninklijke-philips-300797155.html

SOURCE Research and Markets